Re: pprom and antibiotics

From: Henry Gregor (henrygregor@yahoo.com)
Mon Aug 8 16:35:06 2005


And if positive...continue the pregnancy and continue antibioitcs? Why would the perinatologists not accept an infant for care, and take due note of the culture result when available?

Hank

ainsron <ainsron@sbcglobal.net> wrote:

When I’ve discussed similar scenarios with our perinatologists, they want the patient on antibiotics until the GBS culture returns, then if negative discontinue.

Ronald E. Ainsworth, MD, FACOG

-----Original Message----- From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of Richard Chudacoff, MD Sent: Monday, August 08, 2005 8:30 AM To: Multiple recipients of list OB-GYN-L Subject: pprom and antibiotics

I have a question, which Bob Carpenter and I have discussed, but I wanted the groups opinion.

18 yo G1 at 35 weeks, PPROM. Started on Amp and Erythromycin prophylactically, but could not tolerate the Erythro, so this was stopped. GBS came back negative. Patient is now 36 weeks. My question is, in the face of data that shows in increase in resistance and necrotizing enterocolitis with ampicillin, Unasyn or Augmentin without erythromycin, would you continue the ampicillin? Now, let’s add the fact that the baby has gastroschisis…what would your antibiotic option be?

Richard Chudacoff, MD, FACOG

Women's Specialists of Houston

6624 Fannin Suite 1800

Houston, TX, 77030

713-797-1144

713-425-3071

Email: Richard.Chudacoff@obgyn.net

rchudacoff.md@womenspecialists.com

This message is confidential, intended only for the named recipient(s) and may contain information that is privileged or exempt from disclosure under applicable law. If you are not the intended recipient(s), you are notified that the dissemination, distribution or copying of the messages is strictly prohibited. If you receive this message in error, or are not the named recipient(s), please notify the sender at either the e-mail address or telephone number above and delete this e-mail from your computer.

Tired of spam? Yahoo! Mail has the best spam protection around

/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAoHBwgHBgoICAgLCgoLDhgQDg0N Dh0VFhEYIx8lJCIfIiEmKzcvJik0KSEiMEExNDk7Pj4+JS5ESUM8SDc9Pjv/ wAALCACsAPEBAREA/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL /8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEI I0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVW V1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ip qrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3 +Pn6/9oACAEBAAA/APZaKKKKKKKKKKKhN3bLcLbm4iEzfdjLjcfoOtMXULRt SfTlmBukjErR4OQhOAfTrTLPVLa+uru2h3+ZZSCOYMuMMRkY9eCDVysy88Ra XYyyRSzuzQ/63yYXlEX+8VB2/jWhDNHcQpNE4eORQyMOhB5BpwIIyDkUtFFF FFFFFFFFFFFFFFFFFQG9tVvVsjcRi5ZDIsJYbyo4Jx6VneJdVudGsYL2FYzA tzGlyWBJSNmClh9MjrV+/sYdRtTbTlvLLKzBWI3AHOMjsa5vw1ptlZeItc08 WsKm3uY7mBgo3KroOh64BVh+NLqUd7/wsO2FjdR2r3GluGeSHzAQsgOAMjn5 qd4ajntPFniG1urkXEz/AGeYyCMJnKFfuj/drqTnBx17VzfgS5ifwysTsFvI JZVvlbhll3ksW+vXPpWhrWoHTdPSKzjZrif93bpEm8qO7bR1Cjn8h3rO8DGO PTb+ziaUpa38qJ5wIfacMMg8/wAVRXXiHVEv9bns1tJNO0hVEizEozuF3OFc cDAIHI610NvqEE+lQ6i58iGWFZSZfl2AjPPp1qwjrIgdGDKwyGByCKdRRRRR RRRRRRRRRRVHWNWtdD06S/vN/lRkA7F3HJOB9Oe54punz6nNOzX0drDG6ho4 I3LSJ7sehz7dPU1h+J9Ml1DXbUWkRF79mdre5DhDburr82e4+bBXByDip47i TxHoup6Fqlv5GoRwtFcIoJRsj5ZEPcHg46jvU2lR+JZLOwjvltbTyFQXBDmV 5So5xjAXP41oJpECa5Jq6ySCeSBYGUEbCoJIyMdck81O9jayXsV68CtcxKVj lPVQeoH1qRbeBJ2nWGNZXGGkCjcw9CakrOuvD+j3139rutNt5Z+AZGQZbHTP r+NWRYwC/F7tPnCLyl54Vc5wB0HQflVWz0t9Pv8AU72ObzTfOsoiYbQjKgXG ffArlovDj6a2i3Gp2i3ck1zMuojb5ib5SWVyPQMqjJ7GtHxlJPqD2nhqxjEs l2fOuk37B9nQgkE4ONxwo/GtHSNMijkjvba3n0xGDiSx3DYTnAO0EgdD065r ZoooooooooooooorP/tCDU1v7PT75Y7q2PlyPtyYXIyDg9f5Vk+HNXg8T6Rd aVqXlS3VuDb3iKcpMvI8xT3VuefXNZ3h4T6NPd6WdOub/VrVvKiunY7ZICMx lpDwoA4KjnI6Guot7CRmsrq+kD3tvCY2aLIRi2N3H1UVfooooqKW4ih4dufQ cmkjuoZThX59DxU1FFZt5odtc3hv4JJLO/2hPtMBwzKOisDww9iKtWMNzBaq l3dfapsktKECA+mFHTiodZ1a10PS5tQu2PlxDhR952PAUDuSeKwrDUdZ0v8A s6TWJ45zrFyV+zKBm1LAsoU/xKAMHPTqOK6uiiiiiiiiiiiiuT8Y6EXK67Zw vLLAoW9tUcr9ttwclDjqR1HryO9aY0iz1C70zWrQy2bwRbVCJ5ZeIj/VspHA BwcdsVs0UUUUVHPJ5ULP6Dj61jkkkknJPc06ONpHCoMmteEOsShyCw4JFPoo orOvtFt9R1Oyvrl5H+xMXjhJ/dlyMBiPUdvrVO+tvD3hoS67NaxxSICqsoLM S38KL2LHjA61Q8PajLJNqWsa5ePZTxr8+nyNtW0hGSpP94nk7hx27V0enX8O qafDfW4kEU6hlEiFGx9DVmiiiiiiiiuZ8S6pZ2+pW9nquoyafYmFpi6OUM7g gBAw5464HJyKm0zxO13e29vPpN9ZwXQItLi5AHnEDOCucqSASM9cGugopCQA STgCqM1+4P7sAA9CeppiahMp+baw+mKsxX0UnDZQ+/Spy6Ku4uAPXNQPfwqc Dc30FMe8gkQEhsg5C4ps88Yk2neBgEMOQfwqv5zkeXEoQH+6ME1Pp27e/Xbj n61fooooqrdabZ3txbXFzbpLLaP5kLMM7GxjI/OufvNCm8S+JRNq1msOnacc QxkgtdscHLEf8sxxhe5HPStHUNRul8Q6bpVhsBZXnuiwyFhA2gexLEY/3TWt FNFOpaGRJFDFSVbOCOop9FFFFFFVJp7W7kuNMW88u58rLLFJtlRW6MPT60+C 3YWsMV263MsQGZWQfMR/FjsapW+mXr6mLzUryO4WAt9liii2BMjBZuTlsEjs Bk+tatFQ3efsr7fT9Kzbjidh24x+VR1J5WRwfm9PWo6ckbSbtv8ACMmiNDIx UHBwTSMzEKpzgDjNS2yu8mxeA3U46VojyrWPrgZ5PUk0kd3FK+xSc9siiK6j lbaDtYdjU1FFFNl8wxN5RUSYO0sMjPvXO6b4TEjy3+vTNfahdAecFdlhRRnC KoPKjJ65znNSR67Y6fc3VpZ6VKllYMEuriCNVjiYgH7ucnAIJIHFb6sGUMpB UjIIPBFLRRRRUF7PLbWU08Ns9zLGhKQoQDIewBPArizqes+JoPMj8LW6ywtw /wDaQjnt3/Bdyn2PX3FdD4bk8Rm2ki8Q21skiH93LDLuMg/2hgAH3HX0FbVF FNflGz6Gsmfko395B/hS26iRzGerKdv1pN23Geo4IojYb9pHyucEelTWSlbp l6EAioYX8qYMwyAeRWg0dvdoH9O44xVSW6ZZSImxGOgAxUclw0mSQATwcdxU qIbQGVx82Pk44yaq5Oc5565rVtJjNDlvvLwanooorL1y3u5Ybae03yG1uFme 3RseeoBBX687gD3UVmaTbz3+vaxdfYrqz0++gjRhcLseSUAqzKvUDbgZPUit TT9S0n7UdEsLmN5bKJQYkbd5ajgAn19utadFFFFZP9rsL68kd4YtNssRyTOD kydTg9MDIB98+lN1KysLy9hMdybPU3jLW9xFw7KOo9HAyMqc9a1kUpGqli5A wWPU+9OooqG5nWCPkZLcAVQkG20jV/v5yo9qjgJE6Y67hVi8jRiZoiCM4fHY 1UrXSFBIZh95hVaXTyzsyOOTnBFQNBcW/wAwBHupo81vKZZlLbhlGPaoKtpc I8YV+v3WH94ev1qq6lJGQ/wnFX9N/wBW/wDvVcoooorE1jRtQ1e88qTVntNK 2AyRWw2SytzkGTsuPTB5qjpWuaFYwtaaDpV3LYwMVe4s7UtFuHX5urn1IzXS W9xDd28dxbyLLFIu5HU8EVLRRTXkSJd0jqgJAyxxyegrl9R8FnzHuNE1Gayk eUTyW0zGW2mcHdllJyOecg1f0aDVbm+k1DW7aGC4iTyIY4ZC6berOCRn5jgY 7Ba26KKKpXw3zQp3Paqlwxa4c+hwKtWECkecwOQeKbdR/ZpRLGeHPK9qiu40 RkZBgOucVasJ98flseV6fSrdFVp4JJEKiVQvfK/1qmPJgbORM30+Uf40/cr2 kjLGqFWB4qK6/wCPl/fmrenf6p/96rlFFFFUdbtJ7/Qr6ztn2Tz27xxtnGGK kDmmeHzANDtIre3a2SGMRGBk2mNlGCpH179+tP0uwXTIZIPP8wyzSThcABdz ZIUegJ/Wr1FFYfig+HbrT20zX722gjmAdVlnCNweGGT2NclpcmlJqC6Vpviq S1un/wCPeS0ufOgmPo0b7gjewOD2PavRolZIkR3LsqgFj/EfWn0UUVRuVNuG kDbpJDjd/dHtUNnAs8h3k4XnHrWmAAAAMAdqqal/q0+tV7j5reBv9kiooZTD Krjt1+la/mIFDFgAehJphuYB1lX86inu4GhdVkBJGBis9VjI+ZyPYLmpd8aw PGm9i+OSKjmfzH3YI4A5q7p3+qf/AHquUUUUUViapZeIb6+aGz1SDTrDaP3k cO+dj3A3HaB74PWn6T4YsNJumvVkurq9dSr3V1O0jsD29AOOgFbFFFYetaVo F3exz38sNtfbdsU/nBJAPQZ6j2IIqXT9O1Cyu1WSa0urXBPmG3EcwPYfL8p+ uBWvRRRRUc8KzxlDx6H0qG1tWt3YlgQR2q0TgZPArH1XWdKiVVk1OzRg3Iad Qf51XTWNKmsdq6nZsyNkATr0P40z7fZEZF7bY/67L/jTo/Eej7orIXtrcXbP tjhRw7HPsM1p5n7WSD8Kiu71rC0lu7tYLeCFdzyOQAorK8MeKLnxSlzc2dg0 NlE+yK4lwPOPfA7Y4qu/jcSeKI/D+nR/bZwT9oljIEcAHXJ7ken4V0H2iZRm eJXT1FOGIh9otjmP+NPSrqsHUMpyCMiloooorO1m30t7cXequIobcE+Y0zRh c46kEelcppmm6jrmfsdxf6fpgmZlvHuZPNuI85UIjH5VxxuI57Cu7AwMUtFc l4d0DRdQs5rvUrO3vtTklcXr3KB3R9x+TB+6AMYA7YNXvDLwR3Op2NhIZNPt JlSD5tyxsVy6KfQHHHbOO1b9FFFFFFcHoNq/j57rVtamlOnxXLwW2mo5SMBT gtJj7x9jxXQ3Xh3Rbe1VINHsUUHGBbp/hXC3CaDrettoeheG9Nvrlf8AX3cs e2G39eV5Y+wrStvhz4ftty3mnwXMueSEKKPYAHp9a3dM0vT9GBGmWMFpuGCY owCR9etWbi8EEEk9zceXFGpZ3dsBQO9cAy3vxI1IHMtt4ctn4PRrlh/n8PrV vXdZnMqeEPCUYW4C7JpI+EtU7jPY+p/rW74a8NWfhrT/ALPb/vJn5nnYfNI3 9B6CtlHZDlT9R2NWrZtlwFH3JR0qe0Ox5IP7h4+lWqKKKKgvY45LOUS24uVC 7vJIB3kcgc+4rE1HxFqOm6fJfXWlwWVugyXursZz2AVFbJPoKv8Ah6+1HUtH ivNUsRYzykkQA5Krn5c+hI7Vp1FczG3tpJhE8pRS3lxjLN7D3rnbyy8J6/eB tQtUjvSApWffbysPQ9N361v2NhaabaJaWVvHbwRjCxxrgCrFFFFFFVNT1O00 iwkvb6XyoY8ZOCSSeAAByST0ArnrG8v/ALTcXukeDZbcXR3O91dLb+Yf7xjG 7B98ZrnvGHi/XriUeE7PTYYNTvcKTBdeaUU9j8o2nHOew5qHQLXVfD6r4e02 wggvVxJeX7SeakZ9SMDJx0XPHeukl8V2d/d/Y9ItptXuYVAuJoiI4Iz/ALTn jPsM03SNeXV0vJWtkt4bSUx+eku+KXAyWViBkDvXMSyz/EPVGtoGeHw7aP8A vZBwbpx2Ht/+ur3iHW5LSSHwr4ZiQahIoT5BhbSP1PocflVizg0TwBoo+03A 82Y5klI3S3L+w6n2FJ/wmEyatp9jcaPLbnUGxEryAyqv99lAwB7ZzS3fjFrf xGmhQ6W13cuefJnBCD1bjjjmrupeMbbTNasdHtbaTUNRlkAMETAeWp7sT07n FX38QGPx8mgQWbSs8BmmmL4Ea444784/Oumooooorjn0HxHqGv8A9qakNNkW 3b/Qbd5HZLf/AGyoA3OfUnjtXS2EWoR+YdQuoZ2YgoIYjGEHcck5+tXKrag1 0lhM1kYhc7f3fnHCbu2fauD1u9nLNb6z4ltr1GHzadpaBJM+g4dj+a12fh6K 2h0G0S0t7q3gCfJFd7vNUZ/iySa0qKKKKzrfX9MutbudFhug19aoHliwRgH3 79R09as3Vjb3r27XEe820omjz0DgEA/qa5vxZ41TST/ZWjx/2hrk3yxW0Q3e X/tPjp9KZ4H8FvoQl1XVpPtWtXmWmlJ3eXnkqD/M/wBKyvG2p3/iDxLB4I0i UwCRQ99OOqpjJH0x+eQK2IvC2g6Dplvp95e3D2pbYlsz7VmY+qIAXP1zWHr1 xN4u13/hCtDItNKssf2jPEoVQB/yzX+WPX2FXte8R6f4Y8O2ul+GIY57u4Y2 1lHENwDA4Lf7XJ69z+NR6bb6X8O9AvLzUZkvNaki+0XRzud2JwFz2XcQM9+T VbwrpokRvHfi6VWuJhutI3HywIfu7V/vHsBz+JqDxReX8es2V7BbMviC/VoN NtOMWsJ6vJ/tnOfQfgaZLNZfDrSjZacv9q+JdQcJLORuxI3Yn8eF6nqa1tD0 aLwhD9war4p1EF3JOSCepJ/hjB6nv27CugsPC9lEBc6giXuou/my3bLhi/ov oo6Aegrbooooori7rWrm30C6WPUy2sXd8bWOIsN0DNLtAVPZPmz361saNvs9 WvNJ/tCe/SGGOXfcOHkjZiwKkgf7II+tblQXtlb6jZyWd3EJYJRh0J4YelMs dMsNMj8uwsoLVPSKMLn8qtUUUUUVjan4T0XVr1b+5tNl4n3bmCRopB/wJSM0 reGraSPy5r7U5ozwUe9kwfrgg1Z0zQ9L0ZGTTbCG23feKL8zfU9T+NX6yLzw vpV5qw1YxSQX4XYbi3laN2X0ODzVmz0awsZjPFCWnYYM8rmSQj03MSapR+D9 DivLq5jtXU3j77iMTOI5W65K5wep/OpdQ8L6RqdzaXU9sUnsuLeSF2jMY9Bt I4qSTw7pE2mT6bJYxvbXP+uVskyHrkt1J9802x8O6bp5hMcUkrW67YTPK0vl D0XcTj8KNR8OaZqmo2+oXML/AGu3UpHNHK0bBT1GVI45P51HeeFdGvYLWKSz EYs5PNgaFzG0b9yCDnPFXrHTLPTg/wBmhCtIcySMSzufVmPJq1RRRRRRVU6Z YNfi/Nlbm7AwJzEN4H+91qwsaIzMqKpY5YgYz9adRRRRRRRUN5dR2NnNdTbv LhQu20ZJA7AdzTbW+trywhvYpB5E6B0ZuOD0/GnJd20jIqXMTGQEoFcHcB1x 604zwiYQGaPzSMiPcN2PpUV1fRW0LvgzMnWOMgueQOhI6ZqV54Y5EjeaNXf7 qswBb6DvSR3MErukc8bvH99VcEr9fSljuIZXZIpo3ZcbgrAkZ6Zqvd6lFazr bLFLcXDrvEMIBbb0yckADPqafFfwvZrczBrRWJBW4whU5xg847VHPqQh1Szs RFv+1pI6yBuBsA/nupunavDfaRBqMm22SYHiRxxyRjP4VbkuIIYxJLNHGh6M zAA/jSPdW8aqzzxKr8KWcAN9PWpap3Wq2drptzqBmSSG2RncxsG6DOPrU1pM 1xaxzOqoXGcI+8D8e9TUUUUUUUUUUUUUVn6rbT3rW1shdITKJJpUIyoXlRz6 sF7djWFLoN6NMm0g25uLWPUop4GkZfmi8xXcEex3/UYpx8Pzxz3EsNjGjHV4 riNl2giEBN2PTo3Hv70y30O5F/cRX1rdy7r83MV1FMgQjduXOfmBUcY7gehp 1z4fuJNL1sJYobq8vTJE2VyyZQ9e33TxV6G1uLfWr17jTTdrczpLBc5QiNQq jacnI2kEjGc59aztP03WW1izvLqz8kJFOtwqCJU3NjAULyy5HVj+FT6DoVzp kuiN9kSH7Pp7w3RUr98lCM469G5q5dQX9h4jbVLa1a8trm3WGaONlEkbIWKs NxAIO4gjOelNu4LubVbTUZtMae3WCSJrYsjPExYEPgnacgYPPGfrVfTNHvrS 60hpIsR2wui6hwfJWRgUQeuBxx6VRh0TU7WLSJJraaaO2glilghkTdGzNkOA 3ytwMHuM/Wo9T0+W0bTrKG1byvsk6LFNLHI2GYbgQzAcDGCCepHSnQaa9y1t dw2l7c6bPp0dvEitGskW3OdytxhsjkHt9K3tQ0ueXwo+mWbMkot1RBLJknGP lZvcDBPvWTqOj3eoRahJaaZ9jWbTWthAxQebITlTgHGF5GT/AHvauqgQRwRo ECBVA2gYxUlFFFFFFFFRXV1DZWz3NxII4oxlmP8Ank1Qh16B7+GyuLW6s5bg EwG4jAWXAyQCCcHHODg1JpWsQanbq+UilZ5F8kyAt8jlScenGatNeWyu6NcR Bo1LOpcZUDqSO1Mh1KyuLJL2K6ia3cArJvAHPSkm1Kyt5beKa6iR7nPkgt9/ AycfhS3N9FbRM4zMykZjiILckDoSOmaleeGOVYnmjWR/uoWALfQVDFqMDWou Jj9lUsVAnZVOQSPXHOM1LJcwQqGlnjjUjILOAKWW4gg2+dNHHv4XewGfpSyy xwRmSWRY0HVnYAD8aabmARCYzxiNhkPvG0/jSm4gWDzzNGIcZ8wsNuPXPSqu m6mmpSXiom0Ws/k7gwYP8qtuH/fVRy61GGmFtaXV4sDFZWgQEBh1AyRuI9Bm ryXEUiBg4GUD4bggH1Hao53spCiXDW7liNiyFTknpjNSPPBE6RPLGjvwiswB P0FD3EMUiRyTRo7/AHVZgC30HegXELTmBZozKoyYww3AfSqmn6tFe6e95KFt kSaSI+Y4wCjlM598Vbe4gjhEzzRrEeQ5YBfzqMXsbXMUMatIJUZhKhBQYxwT nqc/oaZPqun21tLcy3kKxQ4EjBwdpPABxUpu7YFAbiIGT7mXHzfT1qaiiiis zxBYXGo6S0VmyC5jkjmiDn5WZHDBT7HGKqyxXmt3Gn/aNOksUtLgXEjSujEs oICrtJyMnknHA96yrbQbtbSOy/swQXS6ibk3wZSAnml8g53ZK/LjHf0q5Z6T eQahKkMLfY5BMZFukjYozZI2OPmIJPRu1U00fUIrHQm+wzbbCEw3FvE0YbeV UeYuflboR2ODVtdFa2l0aSGwleG2mmaSOR0d0Dg474xk9B0qKXw/cHSNXRLF PtV1qBljPy7mj8xWHPbhTxV+0tbi21i8NzpxuhcXImhuwUIRdoAU5ORtwcYz nP1rPi03VbbTrK1FlmMT3Ly7Fid13SMUxv8AlAIbk8kU3TfD12BpI1CzST7L p00Em8q4V2ZcD34B5pp0XU4tOsDFDL/aENhHA4kEcsDlf4X3HI5/iXt64rd1 5L2SxhW0gWY+cvnAKrMqc5KB/lJzjr71iWmgXxiso7u0DpFq0lyyuyHbGVba cDjqw4A9afHo1/bJZs9kJ7e21C5ka0Vl5jdm8tlBODtz09/atLw3p81gdTMt oLVLm9aaKMMD8pRR26HIPFVbKLWNIsbvTIrJpyHlezuo5ECkOxYb9xyCC3oc 1Xv7S8a50ktJH/aF3bfY79Nw3GMruZwB/dIYenzUureHp7mbW5ILKNmntYI7 RiVBDJuzj+7jI5pt9olzPq+pfarS6ura/VPLeCVF8sBQCjbuVwQWBX19avwW dxa6zdtcacbyO4ljeC43IfKVVUbTuORggsCM53etUbTR75I7C1ey2XVpe+dL fhlxKm4knOdxLA4II7+wpbfSb+2SylmsvtEcF5dSS2wZSSJHYo4BOCQD0/2j VK7sr2wey/0ZFWS9uJobZnQhAy8IVYhem9uDweBmrGlaYs8GltZ205s7exur WTeyq+4sowCDjkq2COOlJJompSaHf2KQebCYYhbi4jjSYlWyVJXggAcE45Jq 3faddvqIvNOtZYpJBEGinSJ4SqnvzuQjJ+77da6aiiiiiiiiiiiiiiiiiiii m+WnmeZsXfjbuxzj0zTqKKKKZLFFMmyWNJFznDqCKcAFUKoAAGAB2paKKKKK KKKKKKKKKKKKKKKKKKKKKKKKKKKKKK//2Q==





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Thu Oct 2 04:49:47 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.